SanegeneBio

Raises and deals from press releases

• Deal Genentech deal · amount not disclosed · announced Feb 2, 2026 Company release ↗
  Source quote

  • Feb 2, 2026 · Company release ↗
    “BOSTON, SHANGHAI, and SUZHOU – February 2, 2026, SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, today announced a global licensing agreement with Genentech”
• Raise Series B · more than $110M · announced Dec 8, 2025 Company release ↗
  Source quote

  • Dec 8, 2025 · Company release ↗
    “BOSTON, SHANGHAI, and SUZHOU — December 8, 2025, SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced the closing of Series B financing round, raising over $110 million.”

Raises announced in these releases: $110M disclosed.

From the company’s own releases; this list is partial. All raises and deals